Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Teva Pharma Industries Ltd ADR (TEVAy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Teva ADR historical data, for real-time data please try another search
7.70 0.00    0.00%
02/10 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US8816242098 
S/N:  883035
  • Volume: 0
  • Bid/Ask: 7.55 / 7.79
  • Day's Range: 7.56 - 7.70
Teva ADR 7.70 0.00 0.00%

TEVAy Balance Sheet

 
Featured here, the Balance Sheet for Teva Pharma Industries Ltd ADR, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2015
30/06
2015
31/03
2014
31/12
2014
30/09
Total Current Assets 13299 15711 14396 13922
Cash and Short Term Investments 1068 3396 2226 1473
Cash - - - -
Cash & Equivalents 1068 3396 2226 1473
Short Term Investments - - - -
Total Receivables, Net 5568 5508 5408 5410
Accounts Receivables - Trade, Net 5568 5508 5408 5410
Total Inventory 4226 4174 4371 4591
Prepaid Expenses - - - -
Other Current Assets, Total 2437 2633 2391 2448
Total Assets 50371 46951 46420 46608
Property/Plant/Equipment, Total - Net 6427 6349 6535 6551
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 19257 17936 18408 18720
Intangibles, Net 8215 5243 5512 5936
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 3173 1712 1569 1479
Other Assets, Total - - - -
Total Current Liabilities 14473 12467 12289 11669
Accounts Payable 2976 3036 3171 2894
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 3022 1626 1761 1832
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 8475 7805 7357 6943
Total Liabilities 27333 24315 23107 22975
Total Long Term Debt 9496 9391 8523 8818
Long Term Debt 9496 9391 8523 8818
Capital Lease Obligations - - - -
Deferred Income Tax 1976 1044 1101 1229
Minority Interest 47 41 42 37
Other Liabilities, Total 1341 1372 1152 1222
Total Equity 23038 22636 23313 23633
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - - 50 -
Additional Paid-In Capital - - 14121 -
Retained Earnings (Accumulated Deficit) - - 14436 -
Treasury Stock - Common - - -3951 -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 23038 22636 -1343 23633
Total Liabilities & Shareholders' Equity 50371 46951 46420 46608
Total Common Shares Outstanding 852 852 852 854
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Comments

Write your thoughts about Teva Pharmaceutical Industries Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China April 11, 2024 8:30 AM AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical testing AJOVY confirmed a favorable safety profile
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China April 11, 2024 8:30 AM AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical testing AJOVY confirmed a favorable safety profile
TSahi Livnoni
TSahi Livnoni Mar 23, 2024 9:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1% on a Friday with 9.13M volume someone is buying.
TSahi Livnoni
TSahi Livnoni Mar 13, 2024 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
simple story of debt reduction and value going up. revenue growth will set the pace will move up in the next 2-3 years to about 30-40$
ritchie lee
ritchie lee Jan 22, 2024 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
long trend starting
Ramba Łej
Kubizm Jan 22, 2024 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hopefully ! Ive been w8ing for it for 3 y xD
Ramba Łej
Kubizm Sep 14, 2023 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
11,40 will hold as celling or convert to floor :)?
Ramba Łej
Kubizm Aug 02, 2023 8:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looking good on pre-market. Wonder how USA downgrade might spoil the fun here
BumHunters Archer
JohnJenga Aug 02, 2023 8:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
25 next year seems quite doable
Michael Christensen
Michael Christensen Aug 02, 2023 6:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Somebody know the consensus for Q2 today ?
Harel Cohen
Harel Cohen Aug 01, 2023 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
first real report of new CEO... it will be interesting
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email